152 related articles for article (PubMed ID: 27146390)
1. Management of venous thromboembolism in cancer patients: the economic burden of hospitalizations.
Mahé I; Mayeur D; Krakowski I
Support Care Cancer; 2016 Oct; 24(10):4105-12. PubMed ID: 27146390
[TBL] [Abstract][Full Text] [Related]
2. Inpatient costs of endophthalmitis evaluated for the whole of France.
Colin X; Berdeaux G; Lafuma A; Salvanet-Bouchara A; Kodjikian L
Appl Health Econ Health Policy; 2010; 8(1):53-60. PubMed ID: 20038193
[TBL] [Abstract][Full Text] [Related]
3. The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France.
Scotte F; Martelli N; Vainchtock A; Borget I
Adv Ther; 2015 Feb; 32(2):138-47. PubMed ID: 25716549
[TBL] [Abstract][Full Text] [Related]
4. Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database.
Uhart M; Blein C; L'Azou M; Thomas L; Durand L
Eur J Health Econ; 2016 May; 17(4):497-503. PubMed ID: 25962729
[TBL] [Abstract][Full Text] [Related]
5. Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients.
Gussoni G; Foglia E; Frasson S; Casartelli L; Campanini M; Bonfanti M; Colombo F; Porazzi E; Ageno W; Vescovo G; Mazzone A;
Thromb Res; 2013 Jan; 131(1):17-23. PubMed ID: 23141845
[TBL] [Abstract][Full Text] [Related]
6. Cost of venous thromboembolism in hospitalized medically ill patients.
Pendergraft T; Atwood M; Liu X; Phatak H; Liu LZ; Oster G
Am J Health Syst Pharm; 2013 Oct; 70(19):1681-7. PubMed ID: 24048605
[TBL] [Abstract][Full Text] [Related]
7. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
[TBL] [Abstract][Full Text] [Related]
8. Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer.
Khorana AA; McCrae KR; Milentijevic D; Laliberté F; Lejeune D; Crivera C; Lefebvre P
J Med Econ; 2020 Apr; 23(4):323-329. PubMed ID: 31818164
[No Abstract] [Full Text] [Related]
9. Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolism.
Browne C; Lanitis T; Hamilton M; Li X; Horbyluk R; Mardekian J; Kongnakorn T; Cohen A
J Med Econ; 2017 Jan; 20(1):98-106. PubMed ID: 27822962
[TBL] [Abstract][Full Text] [Related]
10. National trends in hospitalizations for venous thromboembolism.
Brahmandam A; Abougergi MS; Ochoa Chaar CI
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):621-629.e2. PubMed ID: 28818212
[TBL] [Abstract][Full Text] [Related]
11. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer.
Lyman GH; Culakova E; Poniewierski MS; Kuderer NM
Thromb Res; 2018 Apr; 164 Suppl 1():S112-S118. PubMed ID: 29703467
[TBL] [Abstract][Full Text] [Related]
12. Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database.
Couturaud F; Mahé I; Schmidt J; Gleize JC; Lafon T; Saighi A; Sedjelmaci F; Bertoletti L; Mismetti P
BMC Cancer; 2023 Jun; 23(1):531. PubMed ID: 37301828
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases.
Heng C; Rybarczyk-Vigouret MC; Michel B
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):144-51. PubMed ID: 25079654
[TBL] [Abstract][Full Text] [Related]
14. Trends in Hospitalization and Mortality of Venous Thromboembolism in Hospitalized Patients With Colon Cancer and Their Outcomes: US Perspective.
Devani K; Patil N; Simons-Linares CR; Patel N; Jaiswal P; Patel P; Patel S; Savani C; Sajnani K; Young M; Reddy C
Clin Colorectal Cancer; 2017 Sep; 16(3):e199-e204. PubMed ID: 27777043
[TBL] [Abstract][Full Text] [Related]
15. Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.
LaMori JC; Shoheiber O; Mody SH; Bookhart BK
Clin Ther; 2015 Jan; 37(1):62-70. PubMed ID: 25524389
[TBL] [Abstract][Full Text] [Related]
16. Hospital incidence and annual rates of hospitalization for venous thromboembolic disease in France and the USA.
Allaert FA; Benzenine E; Quantin C
Phlebology; 2017 Aug; 32(7):443-447. PubMed ID: 27703068
[TBL] [Abstract][Full Text] [Related]
17. [Limits of informations collected from online national database of the ATIH (Agence technique de l'information sur l'hospitalisation): about the paper "Practice uptake in France before and after the 2010 French guidelines on kidney cancer"].
Bensadoun H
Prog Urol; 2014 Jun; 24(7):477-8. PubMed ID: 24861689
[No Abstract] [Full Text] [Related]
18. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates.
Mahan CE; Borrego ME; Woersching AL; Federici R; Downey R; Tiongson J; Bieniarz MC; Cavanaugh BJ; Spyropoulos AC
Thromb Haemost; 2012 Aug; 108(2):291-302. PubMed ID: 22739656
[TBL] [Abstract][Full Text] [Related]
19. Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis.
Steuer CE; Behera M; Kim S; Patel N; Chen Z; Pillai R; Saba NF; Shin DM; Owonikoko TK; Khuri FR; Ramalingam SS
Lung Cancer; 2015 Apr; 88(1):80-4. PubMed ID: 25726042
[TBL] [Abstract][Full Text] [Related]
20. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
